E-LIB Suche - Ergebnisse für: Gonzalez-Montes, Yolanda - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

CD200 genotype is associated with clinical outcome of patie..:

Gonzalez-Montes, Yolanda ; Osca-Gelis, Gemma ; Rodriguez-Romanos, Rocío...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Recovery of uninvolved heavy/light chain pair immunoparesis..:

Lakhwani, Sunil ; Rosiñol, Laura ; Puig, Noemí...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

3

Genetic variants of CTLA4 are associated with clinical outc..:

Gonzalez-Montes, Yolanda ; Rodriguez-Romanos, Rocío ; Villavicencio, Alicia...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

OAB-040: BUMEL vs MEL-200 prior autologous transplant for p..:

Palacios, Juan José Lahuerta ; Ubieto, Ana Jiménez ; Rosiñol, Laura...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S24-S25 , 2022

Link: https://doi.org/10.1016/..

5

Real-World Evidence of Daratumumab Monotherapy in Relapsed/..:

Moreno, David F. ; Clapés, Victoria ; Soler, Juan Alfons...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 8 - p. 635-642 , 2022

Link: https://doi.org/10.1016/..

6

Prognostic Value of Serum Paraprotein Response Kinetics in ..:

Tamariz-Amador, Luis-Esteban ; Rodríguez-Otero, Paula ; Jiménez-Ubieto, Ana...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 9 - p. e844-e852 , 2022

Link: https://doi.org/10.1016/..

7

P-203: Early mortality and treatment discontinuation in mul..:

Oriol, Albert ; Canelo-Vilaseca, Marta ; Sanchez, Carla...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S146-S147 , 2022

Link: https://doi.org/10.1016/..

8

P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB ..:

Gonzalez-Calle, Veronica ; Rodríguez-Otero, Paula ; Sureda, Anna...
HemaSphere. 7 (2023) S3 - p. e954902c , 2023

Link: https://doi.org/10.1097/..

9

Assessment of the psychometric properties of the Spanish ve..:

Dachs, Laura Rosiñol ; Gaisán, Carmen Montes ; Bustamante, Gabriela...
Leukemia & Lymphoma. 64 (2023) 11 - p. 1847-1856 , 2023

Link: https://doi.org/10.1080/..

10

P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN..:

Garcia-Guiñon, Antonio ; Andrea Charry, Paola ; Moraima Jimenez, Maria...
HemaSphere. 7 (2023) S3 - p. e81324da , 2023

Link: https://doi.org/10.1097/..

11

Prognostic Value of Serum Paraprotein Response Kinetics in ..:

Tamariz-Amador, Luis-Esteban ; Rodríguez-Otero, Paula ; Jiménez-Ubieto, Ana...
Clinical Lymphoma, Myeloma & Leukemia. , 2022

Link: https://ddd.uab.cat/reco..

12

ICO-ICS Praxis per al tractament mèdic i amb irradiació del..:

Alcalde Rodrigo, Maria ; Antonio, Maite ; Auñón-Sanz, Carme...
ICO-ICSPraxi;. , 2021

Link: https://hdl.handle.net/1..

13

Bortezomib, lenalidomide, and dexamethasone as induction th..:

Rosiñol, Laura ; Oriol, Albert ; Rios, Rafael...
http://hdl.handle.net/10668/14471. , 2019

Link: http://hdl.handle.net/10..

14

Bortezomib, lenalidomide, and dexamethasone as induction th..:

Rosiñol, Laura ; Oriol, Albert ; Rios, Rafael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888142/. , 2019

Link: http://www.ncbi.nlm.nih...

15

Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethas..:

Dimopoulos, Meletios A. ; Schjesvold, Fredrik ; Doronin, Vadim...
Blood Cancer Journal. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

1-15

Related subjects